黑料网

Professor Lora Heisler

Professor Lora Heisler
Professor Lora Heisler
Professor Lora Heisler

FRSE

Chair in Nutritional Neuroscience

黑料网
Email Address
lora.heisler@abdn.ac.uk
Telephone Number
+44 (0)1224 437446
Office Address

The Rowett Institute, office 4.056
Foresterhill
AB25 2ZD

School/Department
School of Medicine, Medical Sciences and Nutrition




Biography

Professor Heisler investigates brain circuits regulating energy homeostasis in an effort to identify new targets amenable to obesity and type 2 diabetes medications.  Professor Heisler received her PhD from Tufts University, USA in 1997 and held postdoctoral positions at the University of California, San Francisco USA and Beth Israel Deaconess Medical Center, Harvard Medical School USA.  In 2001, Professor Heisler was promoted to Instructor and set up her laboratory at Harvard.  She then relocated her group to the University of Cambridge, UK in 2004 where they worked for the next 10 years.  Prof Heisler was a Wellcome Trust Senior Fellow at this time.  The Heisler laboratory moved to the Rowett Institute, 黑料网 to take advantage of the Institute’s strengths in obesity research, ranging from molecules to man.

 

News 

Recent interview with BBC Scotland and STV about our research. 

LH NauseaSTV filming3.jpg.jpegIMG_9044.jpg

The MOOMIN (Mechanisms Of Obesity, Metabolism, Insulin Sensitivity and Nutrition) Lab welcomes new lab member Mansi Tiwari.

IMG_5692.jpegWhimsical Moomin Lab-Bot Adventure.png

We also welcome Honour's students Leo Gunn and Rhodri Jackson.

Screenshot 2026-01-22 at 11.46.41鈥痑m.png

Congratulations to PhD student Dhamyaa Al-Halboosi on successfully defending her viva and being awarded her PhD.

Screenshot 2026-01-22 at 11.43.01鈥痑m.png

Congratulations MSc student In Imogen McMichael on successfully awarded her degree.

Read Prof Heisler's interviews in the New Scientist in 2026. 

Sign up to attend the Aegean meeting co-organised by Prof Heisler 'international Conference on Obesity - Biological Drivers and Therapeutic Approaches' 6-11 May 2027, Crete.

 

IMG_6712.jpeg

 

Memberships and Affiliations

Internal Memberships

Director of Research, Rowett Institute

Aberdeen Cardiovascular and Diabetes Centre member

External Memberships

Deputy Editor, Molecular Metabolism

Scientific Advisory Board, Keystone Symposia

Latest Publications

  • AAV-mediated delivery of leptin but not adiponectin improves metabolic health in a pre-clinical mouse model of congenital generalised lipodystrophy

    Sommer, N., Roumane, A., Tiwari, M., Han, W., Heisler, L., McIlroy, G. D., Rochford, J.
    Gene Therapy
    Contributions to Journals: Articles
  • Nucleus raphe magnus serotonin neurones bidirectionally control spinal nociceptive transmission in mice

    Grivet, Z., Verboven, A., Aby, F., Bouali-Benazzouz, R., Dhellemmes, T., Perrot, E., Beyeler, A., Heisler, L. K., Balia, M., Battefeld, A., Martin, H., Retailleau, A., Maingret, F., Fioramonti, X., Landry, M., De Koninck, Y., Benazzouz, A., Fossat, P.
    British Journal of Anaesthesia, vol. 137, no. 1, pp. 193-209
    Contributions to Journals: Articles
  • Mesenchymal-specific Alms1 knockout in mice recapitulates metabolic features of Alstr枚m syndrome

    McKay, E. J., Luijten, I., Weng, X., Martinez de Morentin, P. B., De Frutos Gonz谩lez, E., Gao, Z., Kolonin, M. G., Heisler, L. K., Semple, R. K.
    Molecular Metabolism, vol. 84, 101933
    Contributions to Journals: Articles
  • Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation

    Leeson-Payne, A., Iyinikkel, J., Malcolm, C., Lam, B. Y. H., Sommer, N., Dowsett, G. K. C., Blanco Martinez de Morentin, P., Thompson, D., MacKenzie, A., Chianese, R., Kentistou, K. A., Gardner, E. J., Perry, J. R., Grassmann, F., Speakman, J., Rochford, J., Yeo, G. S. H., Murray, F., Heisler, L.
    Cell Metabolism, vol. 36, no. 5, pp. 1076-1087
    Contributions to Journals: Articles
  • GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy

    Roumane, A., Mcilroy, G. D., Sommer, N., Han, W., Heisler, L. K., Rochford, J. J.
    Frontiers in Endocrinology, vol. 15, 1379228
    Contributions to Journals: Articles

View My Publications

Prizes and Awards

Professor Heisler was the recipient of the Outstanding Scientific Achievement Award (OSAA) from the American Diabetes Association.  Professor Heisler received the OSAA prize for her research identifying a new type of medication to improve type 2 diabetes.  This prestigious award recognises research in diabetes that demonstrates particular independence of thought and originality.  Her career scientific contributions include seminal discoveries in the brain control of appetite and blood sugar that demonstrate her innovation.

Professor Heisler commented: “Diabetes is such a widespread problem and it is crucial that we as scientists continue to research this disease in order to find new ways to combat it.  It is extremely humbling to be recognised for our contribution to diabetes research. I work alongside many talented colleagues."

Professor Heisler was also the recipient of the Outstanding Scientific Achievement Award from the Obesity Society for her work defining the therapeutic mechanism of a globally prescribed obesity medication. 

She has lately received the Gill Transformative Research Award for her contributions to obesity treatment.

She has received similar prizes from other international societies and is regularly invited to give Keynote talks at scientific conferences.

Research

Research Overview

MOOMIN Lab

Mechanisms Of Obesity, Metabolism, Insulin Sensitivity and Nutrition

 

Prof Lora HeislerThe brain represents the master coordinator of appetite and energy expenditure, employing interwoven neurological circuits to continually appraise and respond to changes in energy state.

Our research aims to discover and characterise these brain circuits using cutting edge technology with the objective of locating points within the pathway that are amenable to manipulation with manmade (drug) or natural (hormone) substances.

We also examine the impact of diet and body weight on circuit rewiring and mechanisms restore appropriate system connectivity and activity.

The ultimate aim of our research is to identify new treatments for obesity and type 2 diabetes.

Cells in the brain that impact appetite

Our work identifying a new treatment for type 2 diabetes is on the journal cover

Cells in the brain that impact appetite Our work identifying a new treatment
for type 2 diabetes is on the journal cover

 

Current Research

Current projects include: 

  • Identifying the brain mechanism of action of GLP-1 receptor obesity medications
  • Defining how mutations in the orphan receptor GPR75 are protective for the development of obesity, type 2 diabetes and fatty liver disease
  • Establishing how factors within the brainstem nucleus of the solitary tract (NTS) control food intake and body weight
  • Defining how the brain serotonin circuits control physical activity and energy expenditure and how this circuitry become disrupted with ageing
  • Targeting brain serotonin receptors for the treatment of type 2 diabetes

 

Research team:

  • Dr Alasdair Leeson Payne - Research fellow
  • Dr Shuwen Mu - Research fellow
  • Dr Merve Oncul - Research fellow
  • Dr Aurelio Franco Garcia - Research fellow
  • Dr Chinmai Patibandla - Research fellow 
  •  - Laboratory Manager
  • Miss Dhamyaa Al-Halboosi - PhD Student
  • Mr Oghenekaro Iredje, PhD Student
  • Miss Imogen McMichael - MSc Student 
  • Miss Caitlin Gillespie - Honours Student
  • Miss Iona Sinclair - Honours Student
  • Miss Margaux Chekroun - Honours Student

 

Funding and Grants

BBSRC

MRC

Diabetes UK

Wellcome Trust

Medical Research Scotland

Teaching

Teaching Responsibilities

Frontiers of Biomedical Science - SM3002

Publications

Page 6 of 6 Results 51 to 56 of 56

  • Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors

    Lam, D. D., Przydzial, M. J., Ridley, S. H., Yeo, G. S. H., Rochford, J. J., O'Rahilly, S., Heisler, L. K.
    Endocrinology, vol. 149, no. 3, pp. 1323-1328
    Contributions to Journals: Articles
  • Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways

    Zhou, L., Sutton, G. M., Rochford, J. J., Semple, R. K., Lam, D. D., Oksanen, L. J., Thornton-Jones, Z. D., Clifton, P. G., Yueh, C., Evans, M. L., McCrimmon, R. J., Elmquist, J. K., Butler, A. A., Heisler, L. K.
    Cell Metabolism, vol. 6, no. 5, pp. 398-405
    Contributions to Journals: Articles
  • Self-Defeating Personality Disorder Reconsidered

    Cruz, J., Joiner, T. E., Johnson, J. G., Heisler, L. K., Spitzer, R. L., Pettit, J. W.
    Journal of Personality Disorders, vol. 14, no. 1, pp. 64-71
    Contributions to Journals: Articles
  • Reduction of Fat and Protein Intakes But Not Carbohydrate Intake Following Acute and Chronic Fluoxetine in Female Rats

    Heisler, L. K., Kanarek, R. B., Homoleski, B.
    Pharmacology Biochemistry and Behavior, vol. 63, no. 3, pp. 377-385
    Contributions to Journals: Articles
  • Knockout Corner: Neurobehavioural consequences of a serotonin 5-HT2C receptor gene mutation

    Heisler, L. K., Tecott, L. H.
    International Journal of Neuropsychopharmacology, vol. 2, no. 1, pp. 67-69
    Contributions to Journals: Articles
  • Prior Exposure to Palatable Solutions Enhances the Effects of Naltrexone on Food Intake in Rats

    Kanarek, R. B., Mathes, W. F., Heisler, L. K., Lima, R. P., Monfared, L. S.
    Pharmacology Biochemistry and Behavior, vol. 57, no. 1-2, pp. 377-381
    Contributions to Journals: Articles
Show 10 | 25 | 50 | 100 results per page

Refine

Contributions to Journals

Working Papers